ecrin-mdr-crcClinical2012Colorectal NeoplasmsColorectal Cancer MetastaticColorectal NeoplasmsColorectal Cancer MetastaticInterventionalhttps://newmdr.ecrin.org/Study/2123274Puerto RicoUnited StatesCzechiaThailandRussiaNetherlandsSwedenIrelandBrazilSloveniaChileColombiaHungaryUnited KingdomSpainIndiaLebanonCanadaTurkeyBelgiumNorwayFinlandDenmarkItalyMexicoIsraelGermany5AfliberceptECRIN MDRCompletedfalseSafety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based RegimenPrimary Objective: To provide metastatic colorectal cancer participants with access to aflibercept and to document the overall safety in these participants Secondary Objective: To document the Health-Related Quality of Life of aflibercept in this participants population2012-05-152123274NCT01571284U1111-1125-89492011-005724-17